News

This fixed-dose combination product was developed for use in treating children with HIV/AIDS and is based on the adult-strength, brand version of the product EPZICOM, by Viiv Healthcare.

CF102 is a small orally bioavailable drug which bind with high affinity and selectivity to the A3 adenosine receptor. The latter is highly expressed in tumor cells whereas

Galen US will market DaunoXome in the US. KS is a type of cancer that affects both the skin and organs inside the body, such as the lungs,

Northera has received orphan drug designation from the FDA to treat rare diseases/disorders. Neurogenic OH is a chronic neurogenic disorder resulting from deficient release of norepinephrine, the neurotransmitter

Teriflunomide is an immunomodulatory, disease-modifying oral drug with anti-inflammatory properties, and is under investigation for the treatment of MS. The purpose of the MAA is to secure approval

As per the agreement, Actelion will receive exclusive rights to commercialize XIAFLEX (collagenase clostridium histolyticum) in Canada, Australia, Brazil and Mexico upon receipt of the respective regulatory approvals.

CliniWorks’ AccelFind software will be interfaced to Southampton’s clinical systems to extract and de-identify information about cancers and other diseases, and heart and blood conditions from one million

The primary objective of the placebo-controlled study is to evaluate safety, tolerability, pharmacokinetics and pharmacodynamic profile of single ascending doses of Vasomera administered subcutaneously to patients with essential

Silenor could be the first and only prescription therapy for insomnia in Canada that is not a controlled substance, if approved. Paladin has gained commercialization rights to Silenor